TTM
−$20.38M
YoY change
+185.8%
5Y CAGR
—
Peak year (2017)
−$1.71M
Cumulative operating income
−$218.50M
Operating Income history chart for Equillium (EQ) from 2017 to 2025
Latest: −$23.63M
Operating Income growth chart for Equillium (EQ) from 2017 to 2025
Latest: +185.8%
Operating Income history table for Equillium (EQ) from 2017 to 2025
| 2025 | −$23.63M | +185.8% | −$15.37M | ||
| 2024 | −$8.27M | -43.1% | +$6.25M | ||
| 2023 | −$14.52M | -76.6% | +$47.55M | ||
| 2022 | −$62.08M | +64.3% | −$24.29M | ||
| 2021 | −$37.79M | +27.9% | −$8.24M | ||
| 2020 | −$29.55M | +10.6% | −$2.82M | ||
| 2019 | −$26.73M | +210.2% | −$18.11M | ||
| 2018 | −$8.62M | +403.2% | −$6.90M | ||
| 2017 | −$1.71M | — | — |
- 2025−$23.63M+185.8%
- 2024−$8.27M-43.1%
- 2023−$14.52M-76.6%
- 2022−$62.08M+64.3%
- 2021−$37.79M+27.9%
- 2020−$29.55M+10.6%
- 2019−$26.73M+210.2%
- 2018−$8.62M+403.2%
- 2017−$1.71M—
Operating Income values are taken from Equillium's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Equillium (EQ)
According to Equillium's latest reported financial statements, the company's current operating income (TTM) is −$20.38M. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Equillium (EQ) operating income is −$23.63M – surged 185.8% year-over-year.
The record annual operating income stands at −$1.71M, reached in 2017; the historical low of −$62.08M was recorded in 2022.
Equillium Operating Income by Year
Equillium Operating Income 2025: −$23.63M
2025's operating income for Equillium came in at −$23.63M, surged 185.8% from 2024.
Equillium Operating Income 2024: −$8.27M
Equillium posted operating income of −$8.27M in 2024, plunged 43.1% below 2023.
Equillium Operating Income 2023: −$14.52M
In 2023, Equillium reported operating income of −$14.52M, plunged 76.6% below 2022.
Equillium Operating Income 2022: −$62.08M
Equillium operating income in 2022 was −$62.08M, surged 64.3% from 2021. This figure represents the lowest annual value in the available history.
Equillium Operating Income 2021: −$37.79M
Equillium operating income in 2021 was −$37.79M.
See more financial history for Equillium (EQ).
Sector peers by Operating Income
Healthcare peers of Equillium (EQ), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Equillium (EQ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation